AstraZeneca and MSD's breast cancer drug Lynparza receives EC approval - PMLiVE

Retrieved on: 2022-08-04 18:11:42

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca and MSD's breast cancer drug Lynparza receives EC approval - PMLiVE. View article details on hiswai:

Excerpt

AstraZeneca (AZ) and MSD's – known as Merck & Co in the US and Canada – Lynparza (olaparib) has been approved by the European Commission (EC) for ...

Article found on: www.pmlive.com